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ABSTRACT The detection of laboratory cross-contamination and mixed tuberculosis
infections is an important goal of clinical mycobacteriology laboratories. The objec-
tive of this study was to develop a method to detect mixtures of different Mycobac-
terium tuberculosis lineages in laboratories performing mycobacterial next-generation
sequencing (NGS). The setting was the Public Health England National Mycobacteri-
ology Laboratory Birmingham, which performs Illumina sequencing on DNA ex-
tracted from positive mycobacterial growth indicator tubes. We analyzed 4,156 sam-
ples yielding M. tuberculosis from 663 MiSeq runs, which were obtained during
development and production use of a diagnostic process using NGS. The counts of
the most common (major) variant and all other variants (nonmajor variants) were
determined from reads mapping to positions deﬁning M. tuberculosis lineages. Ex-
pected variation was estimated during process development. For each sample, we
determined the nonmajor variant proportions at 55 sets of lineage-deﬁning positions.
The nonmajor variant proportion in the two most mixed lineage-deﬁning sets (F2 met-
ric) was compared with that of the 47 least-mixed lineage-deﬁning sets (F47 metric). The
following three patterns were observed: (i) not mixed by either metric; (ii) high F47 met-
ric, suggesting mixtures of multiple lineages; and (iii) samples compatible with mixtures
of two lineages, detected by differential F2 metric elevations relative to F47. Pattern ii
was observed in batches, with similar patterns in the M. tuberculosis H37Rv control pres-
ent in each run, and is likely to reﬂect cross-contamination. During production, the pro-
portions of samples in the patterns were 97%, 2.8%, and 0.001%, respectively. The F2
and F47 metrics described could be used for laboratory process control in laboratories
sequencing M. tuberculosis genomes.
KEYWORDS Mycobacterium tuberculosis, next-generation sequencing, quality control,
mixed infection, cross-contamination
Mycobacterium tuberculosis is an organism which has coevolved with humansduring the early migrations of modern humans, diverging from a common M.
tuberculosis ancestor about 75,000 years ago (1). Distinct lineages, corresponding to
evolution occurring during these early migrations, are readily identiﬁed by next-
generation sequencing (NGS), with each lineage characterized by ancient single-
nucleotide variants (SNVs) which deﬁne deep branches in theM. tuberculosis phylogeny
(1, 2).
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Multiple M. tuberculosis lineages. Infection by multiple lineages of tuberculosis
(TB) is well described and has been detected by observing mixed results on fractional
sequencing (e.g., spoligotyping and mycobacterial interspersed repetitive-unit–
variable-number tandem-repeat [MIRU-VNTR]) and validated by the characterization of
multiple individual picks from solid medium (3). Multilineage infection is characterized
by isolates differing by many hundreds of SNVs, in which respect it differs from the
increasingly recognized and more common in-host microevolution (4). Reported rates
of mixed infection vary markedly, as reviewed previously (3, 5), with rates between 10%
and 30% reported in areas of current (5–7) or historical (8, 9) high prevalence. Much
lower rates are reported in low-incidence countries (3), although systematic underde-
tection is likely to occur due to both the limited representation of bacteria in single-
sputum samples of pulmonary disease and the decrease in diversity occurring during
differential strain growth in broth culture (10).
Implications of mixed infection. Mixed infection, assessed by either MIRU-VNTR
polymorphisms (7) or by heterogeneity in drug susceptibility testing (11), is indepen-
dently associated with reduced drug treatment response, so there are compelling
clinical reasons to try to identify it. There are also important technical implications of
isolating mixed TB strains from a culture. First, such a ﬁnding may reﬂect cross-
contamination within the laboratory (3). Second, mixed infection complicates the
interpretation of drug resistance tests, whether phenotypic or genotypic, as one or
other coinfecting strains may dominate the results from these tests. Third, it compli-
cates the understanding of relatedness when techniques, such as SNV distance com-
putation, are applied, as these generally assume that a single sequence is present when
basecalling (5, 12–14), marking mixed sites as uncertain. Maximal likelihood tree
drawing algorithms assume that such “uncertain” sites contain no information and
impute a single nucleotide at each of such positions, an approach which may be
inappropriate in the presence of mixtures.
Increasingly, NGS-based species and resistance determination is becoming routine
in mycobacteriology laboratories and has been deployed in reference laboratories in
England (15, 16). As part of the quality control and accreditation of the routine process
now operating in these laboratories, we describe an approach to identifying mixed
samples using Illumina next-generation sequencing data, illustrating its use by studying
over 4,000 consecutive positive cultures from a single reference laboratory.
MATERIALS AND METHODS
Isolation of DNA from mycobacteria and sequencing. This study includes all mycobacteria
processed between 01 June 2015 and 30 December 2017 in the Public Health England Midlands and
North Reference Laboratory, whose catchment is approximately 15 million people, or about one-third of
England. Clinical specimens were decontaminated and inoculated into mycobacterial growth indicator
tubes (MGIT). During the process (Fig. 1), positive MGITs were batched when they became available,
either following growth in the local laboratory or following receipt from another laboratory. Since a
positive MGIT may contain more than one M. tuberculosis strain, and since subculture is not performed
prior to DNA extraction and sequencing, the DNA extracted from such MGIT cultures may derive from
multiple M. tuberculosis strains. Positive-control samples (H37Rv strain) were also grown in MGIT cultures.
Batches of positive samples were extracted using a manual process, exactly as described in the
supplemental methods in a previous study (16). Illumina sequencing libraries were prepared using
Nextera XT chemistry from equal amounts of 12 (from 20 April 2015 to 31 July 2015) or 16 (from 01
August 2015 to 30 December 2017) mycobacterial DNA extracts (16), using manual steps (Table 1).
Positive-control DNA (H37Rv, obtained from ATCC) was included as one of the 12 or 16 extracts in all
libraries, either from a contemporaneously extracted broth culture or from stored DNA. Libraries were
loaded into an Illumina MiSeq instrument and sequenced (16).
Routine bioinformatic processing. The routine bioinformatics pipeline deployed by Public Health
England has been previously described (15). Brieﬂy, reads were ﬁrst processed using the Mykrobe
predictor tool, which identiﬁes Mycobacterium tuberculosis bacteria using species-speciﬁc k-mers (17).
Specimens identiﬁed as containing M. tuberculosis bacteria were further processed (16) and mapped to
the H37Rv v2 genome (NCBI RefSeq no. NC_000962.2) (18), as described previously (16), and vcf ﬁles were
generated using SAMtools mPileup, with additional basecalling using GATK VariantAnnotator v2.1. A
consensus base is called from high-quality bases provided one base accounts for 90% of the pileup;
otherwise, the base is recorded as uncertain (“N”) (15).
Estimation of the minor variant frequency within a set of lineage-deﬁning positions. In this
study, we evaluated an additional step not present in the production pipeline. This evaluates high-quality
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base counts (identiﬁed by the BaseCounts VCF tag) at positions known to be lineage associated (2), which
were extracted and summarized using code available at https://github.com/davidhwyllie/VCFMIX. We
elected to study sites known to be subject to lineage-speciﬁc variation to maximize power in detecting
interlineage mixtures, as nonlineage-associated sites can appear to be mixed for technical reasons, e.g.,
due to mismapping. Coll et al. (2) described the M. tuberculosis phylogeny and identiﬁed 62 sets of
nucleotide positions deﬁning the deep branches of the Mycobacterium tuberculosis lineage. At each
position within a nucleotide set, in one particular clade, one nucleotide is uniquely present (i.e., is not
present in any other of the known clades). These sets contain a median of 108 nucleotide positions
(range, 1 to 898 positions). In this analysis, we considered 55 branches, excluding branches 1.2, 3.1, 3.1.2,
4.1.2, 4.3.4.2.1, 4.6, and 4.7 because they contain fewer than 20 positions, making estimates of minor
variation in these positions less reliable than estimates in other branches.
FIG 1 Laboratory and bioinformatic processing. GP, general practitioner; ve, negative; ve, positive; LIMS, lab
information management system.
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The minor variant frequency at a set of bases can be due to sequencing error, mapping error, and/or
bona ﬁde interlineage mixtures (see Fig. S1A and B in the supplemental material). Minor variant
frequencies were determined as follows: if there are n bases in a lineage-deﬁning set, we count the
high-quality depths (d) at each base, e.g., if n  3 and d1  30, d2  70, and d3  100, the total depth
(D) is
D
i1
n
di 200 (1)
For each position, we also identify the most common base; the minor depth, m, is the total depth
minus the most common base depth. If the minor depths are m1  3, m2  7, and m3  10, the total
minor depth (M) is
M
i1
n
mi 20 (2)
We estimate the minor allele fraction p in the set as M/D  0.1.
F2 and F47 metrics. If sequences from two different M. tuberculosis lineages are mixed together, the
sets which uniquely deﬁne these lineages are mixed (Fig. S1C); there are a minimum of two and
maximum of eight sets affected (e.g., a lineage 5/7 mixture mixes two sets of lineage-deﬁning nucleo-
tides, a 2.1/4.2.1 mixes ﬁve sets, and a 4.1.1.1/3.1.2.1 mixture mixes 8 sets). Only if more than two samples
are mixed will more than 8 sets be mixed. In this work, we describe two metrics reﬂecting mixing. Having
computed the minor allele frequency estimates of p1, p2, and p55, we can sort these in descending order,
identifying the sets with the highest and lowest minor allele frequencies. We then estimate the minor
variant frequency across the nucleotides in the top two (F2 metric) and lowest 47 (F47 metric) sets. For
example, if there are n47 nucleotides in the lowest 47 sets, we compute F47 by M47/D47, where
M47
i1
n47
mi (3)
and
D47
i1
n47
di (4)
The underpinning assumptions are that mixtures of biological origin are most likely to occur between
two lineages, and, therefore, F2 is the most sensitive metric for identifying these. Since between 2 and
8 sets are mixed in such genuine coinfections, the lowest 47 (55  8) sets are not be mixed; thus, the
F47 metric is more sensitive for identifying laboratory contamination involving more than two samples.
Regression modeling. Because of high leverage by a small number of observations, we used
quantile regression to estimate the relationship between the median values of log-transformed noncall-
able base numbers and log-transformed F47, using the quantreg R package (R 3.3.1).
Lineages to which theM. tuberculosis strains studied belong. To describe the samples studied, we
identiﬁed lineage using consensus basecalling in these 55 branches. If the signature SNV of a branch was
called as uncertain, we called only to the level of the branch deeper (i.e., closer to the root) than the
uncertain call. If more than one different lineage-deﬁning variant was called or we could not call any
lineage-deﬁning positions, we reported the samples as “lineage not deﬁned.” This process does not form
part of the computation of F2 or F47 metrics.
Ethics framework. Only anonymized data were used in this work; therefore, approval from an ethics
institution was not required.
Data availability. The data analyzed are available at https://ora.ox.ac.uk/objects/uuid:5e4ec1f8-e212
-47db-8910-161a303a0757.
RESULTS
Samples studied. A total of 4,156 samples were included since they were identiﬁed
using MyKrobe (17) as belonging to the M. tuberculosis complex and had at least 0.5 
106 read pairs mapped to the H37Rv reference genome, a criterion reﬂecting successful
DNA extraction and sequencing. These sequences were highly diverse, originating from
six branches of lineage 1 (n  320), ﬁve branches from lineage 2 (n  278), ﬁve
branches of lineage 3 (n  1,010), and 30 branches of lineage 4 (n  2,266). A total of
106 samples were from M. bovis or M. africanum, and 176 samples did not have their
lineages deﬁned (but were included in calculations of F2 and F47 metrics).
TABLE 1 Samples analyzed
Development
stage
No. of sequences
(samples and controls) Date range (mo-day-yr)
No. of individuals
providing samples
MiSeq run
identiﬁers
No. of clinical
samples
No. of MiSeq
Runs
Development 938 04-20-2015 to 12-15-2015 630 101–291 776 154
Preproduction 1,167 04-01-2016 to 12-06-2016 753 1152–1522 919 163
Production 2,191 12-07-2016 to 12-30-2017 1,481 1523–2307 1,794 346
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The laboratory processes operated under the following three different phases: in the
ﬁrst phase, development, laboratory processes were being actively reﬁned; in the
second phase, preproduction, laboratory processes were ﬁxed and controlled by stan-
dard operating procedures, with version-controlled changes; and the third production
state was similar to the second, except that the process had received ISO15189
accreditation.
Variation in lineage-deﬁning positions in H37Rv controls. The F2 mixture metric
reﬂects the estimated mixture in the two most-mixed lineage-deﬁning sets; in the
H37Rv controls, this follows a distribution skewed to the right (Fig. 2A). The MiSeq runs
with H37Rv controls with F2 mixture metrics in the top 5% (Fig. 2A) are temporally
clustered (red lines on Fig. 2B and C), with a number of examples in the development
phase. Among clinical (noncontrol) samples, variation in the F2 metric is explained in
part by the MiSeq run (Kruskal-Wallis test, P  1016), and a strong correlation exists
between the F2 metric in H37Rv controls and that in clinical samples on the same plate
(  0.61; 95% conﬁdence interval [CI], 0.56 to 0.61; Spearman’s rank correlation). That
is, in plates with elevated F2 metrics in the H37Rv control, the clinical samples are more
FIG 2 Mixtures in H37Rv controls. (A) Histogram showing the F2 metric, which reﬂects the mixture in the two most-mixed lineage-
associated sets, in H37Rv control DNA. (B) Median F2 metric among clinical samples other than H37Rv; red lines indicate that the F2
mixture metric in H37Rv controls is raised (as shown in panel A). (C) F2 metric for each M. tuberculosis sequence from a clinical sample.
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likely to have elevated F2, as is evident visually (see, e.g., Fig. 2B and C, around run
2,301).
Different patterns of mixtures were observed during development.We ordered
specimens ﬁrst by the order of the plates analyzed and the order in which the
bioinformatics processing was completed, which is the order that an automated quality
control monitoring system would encounter output. During the development phase
(Fig. 3), blocks of samples derived from runs with elevated mixtures in the H37Rv
control are seen (red bars in Fig. 3A), coincident with clear increases in both F2 and F47
metrics (Fig. 3B and C), reﬂecting elevations in mixed bases across most or all lineage-
FIG 3 Mixture metrics in the development phase. (A) Samples are arranged ﬁrst by the order of the MiSeq runs (depicted as solid gray blocks) and the order
bioinformatics processing was completed. Only samples yielding M. tuberculosis are shown, which is why some blocks are longer than others. If the H37Rv
control samples had increased F2 statistics, a red bar is shown above each sample in panel A. (B to D) We depicted the F2 (B) and F47 metrics (C), as well as
the estimated mixture F in each of the 58 lineage-deﬁning sets (D). The arrow illustrates a sample with elevated F2 but low F47 metrics.
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deﬁning positions (Fig. 3D). These blocks of samples typically span multiple MiSeq runs
(Fig. 3A and B). In addition to the blocks of samples with elevated F2 and F47 metrics,
we also observed small numbers of single samples with elevated F2 but not F47 metrics
(Fig. 3B, arrow). The pattern with single samples is expected in cases of interlineage
mixtures of only two samples (see Fig. S1, Supplemental Methods). These patterns were
also seen in the subsequent phases (see Fig. S2 to S5, yellow dots).
Mixtures of multiple lineages are common. Based on the pattern observed in the
development phase, we categorized samples as having one of the following: (i) neither
F2 nor F47 raised, (ii) raised F47, or (iii) raised F2 without raised F47. We deﬁned a raised
F2 and F47 as more than 10 and 5 the respective median metric during develop-
ment in all control and clinical samples, cutoffs which correspond to 4.7% (F2) and 0.2%
(F47) minor variant frequencies across the relevant lineage-deﬁning sets, respectively.
In the preproduction and production phases, F2 and F47 values below these thresholds
(reﬂecting unmixed samples) were observed in 97.5% of the samples studied, raised
F47 and F2 values (reﬂecting a mixture of multiple samples) were in observed 2.5% of
the samples, and six samples (0.001%) had raised F2 but normal F47 values (Table 2).
Isolated F2 metric elevation is rare. Isolated elevation of F2 is expected if bacteria
from two different lineages are mixed. In Fig. 4, we show the minor variant frequencies
from all samples from the six individuals with raised F2 but normal F47 metrics. In one
case, patient 3, two technical repeats of the same sample (sample 2) showed the same
pattern, as did a separate sample taken contemporaneously. In other cases (patients 1,
5, and 6), the mixed pattern was only observed in one out of two positive samples taken
on the same day, and in two cases (patients 2 and 3), only a single sample was positive.
Thus, between 1 and 6 samples of the 4,156 samples studied may truly reﬂect mixed
coinfections.
Impact of interlineage variation on basecalling. One obvious question is whether
very low-level cross-contamination impacts the consensus sequence which can dis-
cerned from the pileup. As cross-contamination increases, at some point minor variant
frequencies in some parts of the genome will start to rise above the 10% cutoff
speciﬁed by the basecalling algorithm. The numbers of uncalled bases will then rise;
this relationship can be observed in Fig. 5, where the number of uncallable bases rises
rapidly when F47 exceeds the cutoff value but only slowly below it. Below the cutoff
value of 4.7% (red line in Fig. 5), which is 10 the median (black line in Fig. 5), the
number of uncallable bases increased by 1.25-fold (95% CI, 1.22- to 1.28-fold) for every
10-fold increase in F47; above the cutoff, the corresponding increase was 9.24-fold
(95% CI, 5.5- to 11.2-fold).
DISCUSSION
In this work, we describe methods for monitoring the presence of mixtures of
Mycobacterium tuberculosis of different lineages. The methods described are computa-
tionally efﬁcient and will add little to the overall costs of sequencing and reporting. Our
approach assumes that multiple lineages and sublineages of M. tuberculosis are being
sequenced contemporaneously; this is the case in our setting and is also true globally
(19, 20).
Using single-nucleotide variants, each of which uniquely deﬁnes a branch in the
phylogenetic tree of M. tuberculosis, we can show two patterns of mixtures. The ﬁrst,
which occurred in about 2.5% of samples during the preproduction and production
phases of our project, is indicative of multiple samples being mixed together, since
TABLE 2 Detection of mixtures in clinical samples
Development stage (n)
No. (%) of mixtures with:
Neither F2 nor
F47 raised
F2 raised, but
F47 normal F47 raised
Preproduction (919) 900 (98) 5 (0.003) 14 (1.1)
Production (1,794) 1,741 (97) 1 (0.001) 52 (2.8)
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mixtures are seen in most or all of the lineage-deﬁning branches. This occurred in
batches, was characterized by cross-contamination at levels of less than 1%, and can be
monitored by a metric we term F47. This pattern likely reﬂects process failures. The
strength of the F47 metric is that the depth analyzed is very high, as about 5,000
nucleotides typically contribute across the lineage-deﬁning sets included in it. If there
is a sequencing depth of 50 to 100 reads at each of these, the effective sequencing
depth analyzed is of the order of 25,000 to 50,000 reads, making the detection of minor
variations at sub-1% levels readily feasible with high statistical conﬁdence. Possible
points of cross-contamination include DNA extraction, which occurs in batches, and
FIG 4 Consistency of isolated F2 elevation in individuals. Six individuals with elevated F2 but not F47 statistics were identiﬁed during the preproduction and
production phases. The observed minor variant proportions for all deep branches analyzed are shown in a heatmap. For example, patient 4 had two samples
taken in December 2015; sample 2 was analyzed twice (sequencing identiﬁcation numbers [IDs] 0d9d5 and 9276f), and sample 3 was analyzed once. A similar
pattern of minor variation is seen in all three samples.
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library preparation, which also occurs in batches. Low-level cross-contamination during
centrifugation of a batch of samples in a microcentrifuge is one possibility. Whether
such cross-contamination would be expected to affect the H37Rv internal control
depends on whether this control is processed end to end with each batch or whether
H37Rv DNA is preprepared and added at the library construction stage.
Such low-level cross-contamination, as observed during our production process and
illustrated in Fig. S2 to S4, is likely to have minimal inﬂuence on inference drawn from
the sequence, unless highly sensitive assays for heteroresistance are required. However,
given the rarity of detection of intersample mixtures during production use of M.
tuberculosis sequencing, repeating extraction and sequencing of samples in batches
with elevated F47 metrics could be considered. A sensitive metric, such as F47, will also
allow the early detection of emerging problems and allow a review of the process as
part of continuous quality improvement.
A second class of mixture, which was rarely detected in this setting, is compatible
with coinfection with two organisms of differing lineages within the patient. This kind
of mixture is clinically relevant (7, 11) and may be underdetected using the laboratory
FIG 5 The relationship between the F47 metric and the number of uncallable bases is shown. The red line corresponds to the cutoff used
to deﬁne F47 as being elevated.
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process we describe here, since culture-based ampliﬁcation can reduce diversity in the
sample inoculated (10). Its frequency may rise if direct-from-sample sequencing is
employed or if samples from areas with high endemicity are studied, but here, we
identiﬁed only one probable case of such mixtures and ﬁve other possible cases.
Conﬁrmatory approaches are available; microbiological techniques conducted sepa-
rately on multiple picks from the same samples have been used as validation (3). A
limitation of this study is that we could not undertake such work, as only multiply
subcultured stored isolates exist for historical samples. Techniques for reconstructing
the contributing sequences also have been described in detail (21–23), and we did not
study them here. Another limitation is that we were not able to consider six of the
lineage-deﬁning sets in the study by Coll et al., because they covered 20 nucleotide
positions; therefore, we considered that they did not contain sufﬁcient information to
be used in F2 or F47 metrics. A consequence is that our method did not identify
mixtures of samples if they only involved mixtures in these excluded branches. Prac-
tically, such observations should be assessed on a case-by-case basis, having reviewed
results from other samples from the same patient, treatment history, and basecalls at
resistance loci for possible heteroresistance. More intensive follow-up could be con-
sidered (3), but there are few data to deﬁne optimal management.
The clinical use of bacterial genome sequencing is rising (16, 17, 24), and given the
importance of M. tuberculosis and the complexity of treatment, M. tuberculosis has been
one of the ﬁrst organisms tested in such a way (15). The processes followed involve
multiple steps at which the opportunity for cross-contamination exists. The availability
of tools monitoring the critical aspects of the laboratory process is required for
accreditation under ISO15189, and the F2 and F47 metrics described here will contrib-
ute to addressing this gap.
SUPPLEMENTAL MATERIAL
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